3 Biotech Stocks That Could Soar in September
Winter seems to always be coming in Game of Thrones, but here in the real world, autumn is on the way. While the leaves will start falling in September, some biotech stocks could be set to soar.
Quite a few biotechs have important catalysts coming up in the next month. Three biotechs that could especially benefit from big news on the way are Alnylam Pharmaceuticals (NASDAQ: ALNY), PTC Therapeutics (NASDAQ: PTCT), and Zogenix (NASDAQ: ZGNX). Here's what they have in store in September.
Image source: Getty Images.
Source: Fool.com
Sarepta Therapeutics Stock
€118.45
0.340%
The community is currently still undecided about Sarepta Therapeutics with 1 Buy predictions and 0 Sell predictions.
With a target price of 130 € there is a slightly positive potential of 9.75% for Sarepta Therapeutics compared to the current price of 118.45 €.
